In treatment of Parkinsonism, L–Dopa is combined with carbidopa mainly :: (A) To decrease dose requirement of L–Dopa, (B) To decrease side effects of L–Dopa, (C) To decrease effectiveness of L–Dopa, (D) To increase crossing of L–Dopa through BBB
Answer is D. None